Actually, previous reports have shown that Ezrin and its binding protein NHERF1 were upregulated in response to estrogen in breast and ovarian cancers (Paradiso et al., 2013), implying that there might be a potential link between Ezrin and estrogen or ER. The gene discussed is NHERF1; the disease is ovarian carcinoma.